Nanoparticle-Based Combination Therapy for Melanoma
- PMID: 35837089
- PMCID: PMC9273962
- DOI: 10.3389/fonc.2022.928797
Nanoparticle-Based Combination Therapy for Melanoma
Abstract
Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious complications; moreover, resistance is common. Nanoparticles (NPs) combined with conventional methods are new and promising options to treat melanoma, and many combinations have been achieving good success. Due to their physical and biological features, NPs can help target intended melanoma cells more efficiently with less damage. This creates new hope for a better treatment strategy for melanoma with minimum damage and maximum efficacy.
Keywords: chemotherapy; combined therapy; immunotherapy; melanoma; nanoparticles; photodynamic therapy.
Copyright © 2022 Chen, Hou, Yu, Wang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Pavlotsky F, Azizi E, Gurvich R, Lusky A, Barell V, Weiner M, et al. . Prevalence of Melanocytic Nevi and Freckles in Young Israeli Males: Correlation With Melanoma Incidence in Jewish Migrants: Demographic and Host Factors. Am J Epidemiol (1997) 146:78–86. doi: 10.1093/oxfordjournals.aje.a009193 - DOI - PubMed
-
- Breitbart M, Garbe C, Büttner P, Weiss J, Soyer HP, Stocker U, et al. . Ultraviolet Light Exposure, Pigmentary Traits and the Development of Melanocytic Naevi and Cutaneous Melanoma. A Case-Control Study of the German Central Malignant Melanoma Registry. . Acta Derm Venereol (1997) 77:374–8. doi: 10.2340/0001555577374378 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
